Reverb Therapeutics, a leader in harnessing the natural immune system and cytokine signaling to treat life-threatening diseases, announced it has closed a $17.2 million (USD $12 Million) financing led ...

Specific inflammatory cytokines can predict infection risk in leukemia in patients undergoing chemotherapy, according to a study in Microbial Pathogenesis.

Data reinforce dose-dependent mechanism with IMNN-001 100mg/m2 dose associated with 20% increase in IL-12 levels compared to 79mg/m2 doseResults ...

Imunon (IMNN) announced new translational data from ongoing analyses of results from the Company’s Phase 2 OVATION 2 Study of IMNN-001, its ...

Researchers have identified key immunological markers associated with mortality in hospitalised people living with HIV/AIDS.

Compugen's innovative approach targets under-explored immune pathways like PVRIG and IL-18 binding protein. Read why I'm ...

New 2-year data show the long-term effects of bimekizumab on hidradenitis suppurativa, indicating its potential as a valuable ...

Researchers from Rice University and Baylor College of Medicine have developed a new treatment that eliminates advanced-stage ...

After fixation and permeabilisation, these cells were stained with fluorochrome-conjugated antibodies against cytotoxic cytokines for 30 min at 4°C. The protocol was designed as a superiority trial to ...

Coya Therapeutics' Phase 2 study shows monthly LD IL-2 improves cognitive scores and reduces inflammation in Alzheimer's patients, with no serious adverse events.

In fact, in pre-clinical and clinical studies, adenoviruses armed with cytokines such as GMCSF, TNFa and IL-2 conferred improved anti-tumor response, with enhanced effector CD8+ T and helper CD4+ T ...

5 Wessex Investigational Sciences Hub, University of Southampton Faculty of Medicine, Southampton General Hospital, Southampton, UK Correspondence to Dr Tom Wilkinson, Clinical and Experimental ...